While the expression of IGFBP-3 may not be completely absent, a decrease in its expression can cause an elevation in the local availability of IGF-1 in lung tissue, thereby increasing the risk of developing lung cancer [64,65]. The gene discussed is IGFBP3; the disease is lung carcinoma.